IDEAYA Biosciences, Inc. financial data

Symbol
IDYA on Nasdaq
Location
5000 Shoreline Ct, Suite 300, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2K % +15%
Debt-to-equity 4.69 % -16.3%
Return On Equity -26.7 % -16.3%
Return On Assets -25.5 % -17.3%
Operating Margin -4.67K % -713%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87.5M shares
Common Stock, Shares, Outstanding 86.5M shares +33%
Entity Public Float 2.7B USD +108%
Common Stock, Value, Issued 9K USD +28.6%
Weighted Average Number of Shares Outstanding, Basic 81.7M shares +42%
Weighted Average Number of Shares Outstanding, Diluted 81.7M shares +42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7M USD -70.1%
Research and Development Expense 295M USD +128%
General and Administrative Expense 39.3M USD +38.8%
Operating Income (Loss) -327M USD -143%
Nonoperating Income (Expense) 52.5M USD +145%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -274M USD -143%
Earnings Per Share, Basic -3.36 USD/shares -71.4%
Earnings Per Share, Diluted -3.36 USD/shares -71.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.4M USD -46.3%
Marketable Securities, Current 592M USD +60.8%
Assets, Current 690M USD +29.5%
Property, Plant and Equipment, Net 8.97M USD +45.5%
Operating Lease, Right-of-Use Asset 18.8M USD +736%
Other Assets, Noncurrent 75K USD -30.6%
Assets 1.12B USD +73.1%
Accounts Payable, Current 15.4M USD +134%
Employee-related Liabilities, Current 8.23M USD +18.1%
Accrued Liabilities, Current 30.4M USD +61.8%
Contract with Customer, Liability, Current 1.44M USD -86%
Liabilities, Current 46.1M USD +70%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 18.9M USD +1578%
Liabilities 64.9M USD +130%
Accumulated Other Comprehensive Income (Loss), Net of Tax 812K USD +44.5%
Retained Earnings (Accumulated Deficit) -623M USD -78.8%
Stockholders' Equity Attributable to Parent 1.06B USD +70.5%
Liabilities and Equity 1.12B USD +73.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -43.8M USD -57.4%
Net Cash Provided by (Used in) Financing Activities 349M USD +11831%
Net Cash Provided by (Used in) Investing Activities -354M USD -1605%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 86.5M shares +33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -48.7M USD -3389%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.2M USD -46%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -7.69%
Deferred Tax Assets, Valuation Allowance 165M USD +71.9%
Deferred Tax Assets, Gross 169M USD +75%
Operating Lease, Liability 19.2M USD +568%
Payments to Acquire Property, Plant, and Equipment 1.33M USD +2981%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -274M USD -150%
Lessee, Operating Lease, Liability, to be Paid 37.8M USD +1081%
Property, Plant and Equipment, Gross 20.7M USD +31.1%
Operating Lease, Liability, Current 298K USD -82.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.71M USD +341%
Lessee, Operating Lease, Liability, to be Paid, Year One 386K USD -79.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +62.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.6M USD +5601%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.39M USD +1003%
Deferred Tax Assets, Operating Loss Carryforwards 37.5M USD +8.09%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.93M USD +55.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.22M USD +930%
Operating Lease, Payments 500K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 616K USD +4.76%
Deferred Tax Assets, Net of Valuation Allowance 4.1M USD +531%
Share-based Payment Arrangement, Expense 34.7M USD +87.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%